MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
SLQT
SelectQuote, Inc.
There isn't enough reported data to score SLQT yet.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
SLQT Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| N/A | |
| N/A |
SLQT's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like SLQT.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
SLQT PE Valuation
SLQT has no meaningful PE right now: it lost money over the past year.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over SLQT on the outlook, with more favorable earnings and revenue expectations.
SLQT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Decline | |
| Weakening | |
| Limited | |
| High |
Analysts expect SLQT's revenue and profitability to decline, with its earnings holding steady.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS has the stronger earnings trend. Trailing diluted EPS is up 29% for MS versus SLQT down 104%.
SLQT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$0.10 | +$0.22 |
| Q4 2024 | -$0.08 | +$0.23 |
| Q3 2024 | -$0.27 | +$0.01 |
| Q2 2024 | -$0.20 | +$0.15 |
| Q1 2024 | -$0.32 | +$0.38 |
| Q4 2023 | -$0.31 | +$0.49 |
| Q3 2023 | -$0.28 | +$1.50 |
| Q2 2023 | -$0.35 | +$1.45 |
SLQT is still losing money, but far less than before: $0.01 per share over the past year, against $1.80 at its worst in mid-2022.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS has the edge over SLQT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over SLQT on profitability, with a higher operating margin.
SLQT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $280M | -15% |
| Q2 2026 | $321.7M | -6.8% |
| Q1 2026 | $430.9M | +5.6% |
| Q4 2025 | $537.1M | +12% |
| Q3 2025 | $328.8M | +13% |
| Q2 2025 | $345.1M | +12% |
| Q1 2025 | $408.2M | +8.4% |
| Q4 2024 | $481.1M | +19% |
SLQT's revenue grew through 2024 and has held roughly level since: $280M last quarter, down 15% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -10% | +2.2 points |
| Q2 2026 | 1.1% | +4.7 points |
| Q1 2026 | 8.3% | +2.9 points |
| Q4 2025 | 14% | -0.7 points |
| Q3 2025 | -12% | -8.3 points |
| Q2 2025 | -3.6% | -3.2 points |
| Q1 2025 | 5.4% | -3.4 points |
| Q4 2024 | 15% | +1.1 points |
SLQT's operating margin was −10% last quarter, up 2.2 points from the same quarter a year ago.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
SLQT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$17.8M | +$4.8M |
| Q2 2026 | -$4.5M | +$33.5M |
| Q1 2026 | $55.8M | -20% |
| Q4 2025 | -$1M | +$28M |
| Q3 2025 | -$22.7M | -$5.6M |
| Q2 2025 | -$38M | -293% |
| Q1 2025 | $70.2M | +62% |
| Q4 2024 | -$29M | -$2M |
SLQT has the edge over MS on cash generation, producing positive trailing cash flow while its opponent burns cash.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over SLQT on shareholder dilution, with a more favorable share count trend.
SLQT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.7% | +3.3M shares |
| 1 year | +3% | +5.6M shares |
| 3 years | +14% | +24M shares |
| 5 years | +17% | +27.8M shares |
| Available history | +39% | +53.3M shares |
SLQT has 191M diluted shares, up 3% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2020 | — |
| Q4 2019 | — |
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
SLQT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.6x | Elevated |
| Q2 2026 | 3.9x | Elevated |
| Q1 2026 | 4.6x | High |
| Q4 2025 | 6.2x | High |
| Q3 2025 | 6.5x | High |
| Q2 2025 | 4.0x | Elevated |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 6.2x | High |
SLQT has the edge over MS on leverage, with a lower net debt burden relative to earnings.
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
SLQT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.3 | Neutral |
| Stochastic | 23.9 | Neutral |
SLQT's weekly RSI is 42 (neutral) and its Stochastic is 24 (neutral).
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
SLQT PE vs Financial Services Sector
| Metric | SLQT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
SLQT has no meaningful PE right now: it lost money over the past year.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS has the edge over SLQT on trend strength, trading above more of its moving averages.
SLQT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.39 | 26% above |
| 20 week MA | $0.55 | 11% below |
| 50 week MA | $0.84 | 42% below |
| 100 week MA | $1.81 | 73% below |
| 200 week MA | $1.90 | 74% below |
SLQT has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 74% below its 200-week average.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over SLQT on returns for 2026, with the stronger performance.
SLQT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $26.5 | $22.3 | -16% |
| 2021 | $22.3 | $9.38 | -58% |
| 2022 | $9.38 | $0.65 | -93% |
| 2023 | $0.65 | $1.37 | +111% |
| 2024 | $1.37 | $3.68 | +169% |
| 2025 | $3.68 | $1.37 | -63% |
| 2026 YTD | $1.37 | $0.49 | -64% |
SLQT's yearly returns have swung widely, from +169% in 2024 to −93% in 2022. It's down 64% so far in 2026.